Alliance Management Expertise, Partnering Frameworks and Tools, Collaborative Leadership

Beyond the Pill Strategies: Biopharma Partnering's Next Frontier
2. Thought Leadership / September 11th, 2017     A+ | a-
Beyond the Pill imageAUTHORS: Jan Twombly and Jeff Shuman
download pdf

Three trends – new technologies, shifting economics, and empowered patients – are disrupting biopharma’s traditional business model. Smart biopharma companies are responding by embracing a holistic “beyond the pill” approach to the future.

For most biopharma companies, beyond the pill is largely a defensive strategy aimed at justifying or preserving pricing or perhaps gaining reimbursement in any amount. If prognosticators are correct, this bundle of product, services, and data (typically referred to as a solution) will be required for receiving regulatory approval in the not-to-distant future. The bundle may even be part of a single label.

Opportunities to create, deliver, and capture value abound across the value chain. All require partnering. Biopharma partnering and alliance professionals should dive in, head first.
No comments posted...
Leave a Comment
* - Required fields
Older Post Home Newer Post